Bio Green Med Solution (BGMS) vs Can-Fite Biopharma (CANF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Can-Fite Biopharma is the larger company by market cap ($6.1 million vs $5.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BGMS | CANF |
|---|---|---|
| Share price | $0.821 | $2.00 |
| Market cap | $5.44M | $6.06M |
| 1-day change | -3.41% | -4.76% |
| YTD return | — | -46.50% |
| 1-year return | — | -82.17% |
| 5-year return | — | -99.31% |
| EPS (TTM) | $-5.02 | $-13.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.70 | $12.40 |
| 52-week low | $0.57 | $1.96 |
| Distance from 52-week high | -87.75% | -83.87% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +300.00% |
| Average volume | 74.44K | 387.60K |
| Shares outstanding | 6.62M | 3.03M |
| Employees | — | 5 |
| Sector | Industrials | Healthcare |
| Industry | Building Products & Equipment | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Bio Green Med Solution in Industrials and Can-Fite Biopharma in Healthcare.
About Bio Green Med Solution
BGMS stock →Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.
Industrials · Building Products & Equipment
About Can-Fite Biopharma
CANF stock →Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis.
Healthcare · Biotechnology · 5 employees
BGMS vs CANF FAQ
Which is bigger, Bio Green Med Solution or Can-Fite Biopharma?
Can-Fite Biopharma (CANF) is larger, with a market capitalization of $6.06M compared with $5.44M for Bio Green Med Solution (BGMS).
Are Bio Green Med Solution and Can-Fite Biopharma in the same industry?
No. Bio Green Med Solution is in the Industrials sector, while Can-Fite Biopharma is in Healthcare.